[{"NetIncomeLoss_1_Q1_USD":410200000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_1_Q1_USD":22400000.0,"LongTermDebt_0_Q1_USD":7267200000.0,"AssetsCurrent_0_Q1_USD":6719500000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":-2700000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":600000.0,"Depreciation_1_Q1_USD":48800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-64700000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":21400000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":14000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":205700000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-4900000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":103300000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":215000000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":212500000.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":-436100000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-174300000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-5600000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-71700000.0,"IncreaseDecreaseInEquitySecuritiesFvNi_1_Q1_USD":-437600000.0,"ShareBasedCompensation_1_Q1_USD":70000000.0,"StockholdersEquityOther_1_Q1_USD":-1500000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":125400000.0,"Assets_0_Q1_USD":23854700000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":2141900000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":634800000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":819200000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":913300000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-800000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q1_USD":0.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":0.0,"AvailableForSaleSecurities_0_Q1_USD":2141900000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":-46800000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":78500000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":478100000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":595000000.0,"TreasuryStockValue_0_Q1_USD":2977100000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":414500000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_1_Q1_pure":0.006,"Liabilities_0_Q1_USD":13191500000.0,"Revenues_1_Q1_USD":2694000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-33000000.0,"CommonStockValue_0_Q1_USD":100000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"IncomeTaxExpenseBenefit_1_Q1_USD":44200000.0,"AccountsReceivableNetCurrent_0_Q1_USD":1854300000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":100000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":821900000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-283600000.0,"PaymentsOfFinancingCosts_1_Q1_USD":24400000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-442300000.0,"MinorityInterest_0_Q1_USD":-19000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":215000000.0,"EarningsPerShareBasic_1_Q1_USD":2.7,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5190300000.0,"IncreaseDecreaseInDueFromRelatedParties_1_Q1_USD":-43800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":152300000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":80900000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":780400000.0,"PaymentsToAcquireInProcessResearchAndDevelopment_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q1_USD":700000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":380000000.0,"OtherAssetsNoncurrent_0_Q1_USD":2423000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":534900000.0,"GoodwillOtherIncreaseDecrease_1_Q1_USD":1000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":112500000.0,"OtherAssetsCurrent_0_Q1_USD":786100000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":146900000.0,"CostsAndExpenses_1_Q1_USD":1720100000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-785000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":514200000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":1320000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.095,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":33800000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-8600000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":8178400000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":-436600000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":2600000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q1_USD":1286300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-80700000.0,"LiabilitiesCurrent_0_Q1_USD":3165800000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":1320200000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":151900000.0,"RepaymentsOfDebt_1_Q1_USD":169300000.0,"AccountsPayableCurrent_0_Q1_USD":430400000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":331300000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-48500000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":1166400000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":27100000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":28100000.0,"Goodwill_0_Q1_USD":5763100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1600000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":124700000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":769000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1827600000.0,"NonoperatingIncomeExpense_1_Q1_USD":-506900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1217500000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3438300000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q1_USD":200000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":11400000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":226000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":966700000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_1_Q1_pure":0.037,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":10663200000.0,"InterestExpense_1_Q1_USD":64700000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":0.0,"AdditionalPaidInCapital_0_Q1_USD":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":400000.0,"EquitySecuritiesFvNiRealizedGainLoss_1_Q1_USD":6200000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2988100000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":700100000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1_Q1_pure":-0.109,"CashEquivalentsAtCarryingValue_0_Q1_USD":745800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":225000000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-18200000.0,"DebtInstrumentFairValue_0_Q1_USD":7859200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":207400000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":23854700000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-15000000.0,"PreferredStockValue_0_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":2900000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-2000000.0,"InventoryNet_0_Q1_USD":1171800000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":-72600000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":64800000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":600000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":467000000.0,"OperatingIncomeLoss_1_Q1_USD":973900000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":781200000.0,"NotesPayable_0_Q1_USD":7267200000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0005,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":725200000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1320000000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1_Q1_USD":91200000.0,"StockIssuedDuringPeriodValueTreasuryStockReissued_1_Q1_USD":19700000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1_Q1_pure":0.008,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":220000000.0,"EarningsPerShareDiluted_1_Q1_USD":2.69,"AssetImpairmentCharges_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-37200000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":13833500000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q1_USD":149600000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_1_Q1_pure":0.008,"TaxesPayableCurrent_0_Q1_USD":143100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":200000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":2140900000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":92600000.0,"StockholdersEquity_0_Q1_USD":10682200000.0,"ConstructionPayableCurrentAndNoncurrent_0_Q1_USD":88600000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2592300000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1411800000.0,"ProfitLoss_1_Q1_USD":404600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":165000000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_1_Q1_USD":17400000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":530000000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210422"}]